Evidence for Ozempic’s broad health benefits is mounting
David J. Phillip / Associated Press / Alamy Stock Photo
The type 2 diabetes drug Ozempic has been linked to slower rates of ageing, and now we have good-quality evidence that this really does occur.
GLP-1 drugs like Ozempic and Wegovy, both of which contain the medication semaglutide, have gained huge prominence for their effects on obesity, but are also being explored for conditions such as cardiovascular disease, addiction and dementia.
Scientists have previously suggested that they might delay biological ageing – the rate at which cells age – largely based on animal studies and observational human data. Now, we have the first clinical trial results…
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We 5guruayurveda.com want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on. For any glitch kindly connect at 5guruayurveda.com
